The FDA has given Moderna the green light to enter into phase two of trials with its vaccine against the novel coronavirus that causes COVID-19
Moderna’s is one of many vaccines against the coronavirus in development. Photo: Douglas Magno/AFP via Getty Images The Food and Drug Administration has given Moderna the green light to enter into phase two of trials with its vaccine against the novel coronavirus that causes COVID-19, in what the Boston biotech firm called a “crucial step forward.”
Phase two will include 600 patients and is planned to begin “shortly,” the company said in a press release Thursday. It is also gearing up for phase three, “which is expected to begin in the early summer of 2020.” That puts Moderna on target to make the vaccine available “as soon as 2021,” it said. But manufacturing would begin sooner. Last week, Moderna’s CEO told CNBC that that firm would start building its stockpile of the vaccine as soon as July.
Moderna’s coronavirus vaccine is one of many in development, but it was the first to begin phase one of testing in March. The trial was funded National Institutes of Health and took place Seattle, one of the early U.S. hot spots of the outbreak. The trail included 45 healthy adults between 18 and 55.
Since the start of trial, the vaccine from a company that has never brought a product to market has made an impression on some important people, including Dr. Anthony Fauci, who told National Geographic that early results from Moderna are “impressive” and said the company’s success gives him hope that people will be able to get vaccinated against the coronavirus by early 2021. Others have warned that talk of such an aggressive timeline is irresponsible.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna shares surge after FDA approves coronavirus vaccine for phase 2 trialModerna has received FDA approval for the company's Covid-19 vaccine to continue into the second phase. CNBC's Becky Quick reports.
Read more »
FDA authorizes antibody test for emergency use to determine coronavirus ImmunityPerkinElmer's serological test is the first of its kind to receive emergency use authorization by the FDA in the fight against the coronavirus pandemic.
Read more »
FDA Approves Diabetes Drug for Type of Heart FailureThe FDA today approved a new use for the diabetes drug, dapagliflozin (Farxiga), to reduce the risk of a hospital stay or death in people who have a type of heart failure.
Read more »
Moderna shares surge after FDA approves coronavirus vaccine for phase 2 trialModerna has received FDA approval for the company's Covid-19 vaccine to continue into the second phase. CNBC's Becky Quick reports.
Read more »
Coronavirus vaccine in human trials relies on body's genetic materialIt's still unclear if the drug will work, and would be months away from potentially being available to the public, but the drug is now a contender to be the first vaccine of its kind ever approved to prevent an infectious disease.
Read more »